• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

information for practice

news, new scholarship & more from around the world


advanced search
  • gary.holden@nyu.edu
  • @ Info4Practice
  • Archive
  • About
  • Help
  • Browse Key Journals
  • RSS Feeds

HIV dramatically increases the risk of HPV-related anal cancer, data show

CIDRAP | National Cancer Institute of Colombia
CIDRAP | National Cancer Institute of Colombia

Although anal cancer rates are increasing, especially in older women, people today have more ways to protect themselves. The Food and Drug Administration has approved Merck’s Gardasil HPV vaccine to prevent six kinds of cancer, including anal cancer. The vaccine protects against nine viral strains, including HPV 16, which causes most anal cancers.

Posted in: News on 07/02/2026 | Link to this post on IFP |
Share

Primary Sidebar

Categories

Category RSS Feeds

  • Calls & Consultations
  • Clinical Trials
  • Funding
  • Grey Literature
  • Guidelines Plus
  • History
  • Infographics
  • Journal Article Abstracts
  • Meta-analyses - Systematic Reviews
  • Monographs & Edited Collections
  • News
  • Open Access Journal Articles
  • Podcasts
  • Video

© 1993-2026 Dr. Gary Holden. All rights reserved.

gary.holden@nyu.edu
@Info4Practice